149 research outputs found
Effects of Oriental medicines on the production of advanced glycation endproducts
Advanced glycation endproducts (AGEs) are largely involved in the pathogenesis of diabetic nephropathy. It is apparent that inhibition of AGEs formation is important in preventing the occurrence and progression of nephropathy. Therefore, to seek possible AGEs inhibitors in Oriental medicines, we began our investigation with an in vitro evaluation system. Among the 12 Oriental medical prescriptions examined, Ompi-to inhibited AGEs formation to the greatest extent, followed by Tokaku-joki-to and Keishi-bukuryo-gan and Daio-botampi-to in that order. Among the 21 component galenicals examined, Rhei Rhizoma, Cinnamomi Cortex, Moutan Cortex and Paeoniae Radix all had a potent inhibitory action, indicating that Rhei Rhizoma, vascular system disturbance -eliminating drugs and tannin-containing crude drugs can all inhibit the formation of AGEs. These Oriental prescriptions and component galenicals proved to have more potent inhibitory activity than the positive control aminoguanidine. advanced glycation endproducts(AGE)ã¯ç³å°¿ç
æ§è
çã®æå ã«å€§ããé¢äžããŠãã,AGEçæã®æå¶ãè
ççºçã»é²å±é²æ¢ã«éèŠã§ããããšãç¥ãããŠããããã®ããšãã,æ¬ç 究ã§ã¯AGEé»å®³è¬ã®å¯èœæ§ãå挢è¬ã«æ±ã,in vitroã®è©äŸ¡ç³»ã§æ€èšããã䜿çšãã挢æ¹æ¹å€12çš®é¡ã®ãã¡,æãAGEçæãæå¶ãã挢æ¹æ¹å€ã¯æž©èŸæ¹¯ã§,次ãã§æ¡æ žæ¿æ°æ¹¯,æ¡æè¯èäžž,倧é»ç¡äž¹ç®æ¹¯ã®é ã§ãã£ããå®éšã«äŸãã21çš®é¡ã®æ§æçè¬ã§ã¯å€§é»,æ¡ç®,ç¡äž¹ç®,èè¬ã«åŒ·ãæå¶äœçšãèªã,倧é»å€,é§ãè¡å€ãªãã³ã«ã¿ã³ãã³çè¬ãAGEã®çæãæå¶ããŠãããã®ãšèããããããŸããããã¯éœæ§å¯Ÿç
§ç©è³ªã®ã¢ããã°ã¢ããžã³ãã匷ã掻æ§ã瀺ãã
A study of Kampo medicines in a diabetic nephropathy model
The effects of four Kampo medicines, Ompi-to, Hachimi-jio-gan, Keishi-bukuryo-gan and Sairei-to, were investigated in rats with diabetic nephropathy induced by subtotal nephrectomy and injection of streptozotocin. To evaluate their effects on the glycation reaction, excessive activity of the polyol pathway and oxidative stress (abnormal bio-chemical processes induced by persistent hyperglycemia), we determined levels of the major endproducts of these processes: advanced glycation endproducts (AGEs) and sorbitol in the kidney and lipid peroxidation in the serum. These three processes were all enhanced in rats with untreated diabetic nephropathy. Oral administration of all four medicines significantly lowered AGEs levels. The renal sorbitol concentration was significantly lowered in the Hachimi-jio-gan-, Sairei-to- and Keishi-bukuryo-gan-treated groups compared with the untreated control group. Serum lipid peroxidation was significantly lowered in the Keishi-bukuryo-gan, Ompi-to and Sairei-to groups, while creatinine clearance and urinary protein excretion (parameters of renal function) were ameliorated by Keishi-bukuryo-gan and Hachimi-jio-gan, respectively, indicating retardation of the progression of diabetic nephropathy. These results suggest the potential therapeutic usefulness of Kampo medicines as a treatment for diabetic nephropathy. It is believed that their actions may occur through different mechanisms. 挢æ¹æ¹å€(æž©èŸæ¹¯,å
«å³å°é»äžž,æ¡æè¯èäžž,æŽè湯)ã®ç³å°¿ç
æ§è
çã«åãŒã圱é¿ã,ã¢ãã«ã©ãããçšãæ€èšãããæ
¢æ§çãªé«è¡ç³ç¶æ
ã§ã¯ç³ååå¿,ããªãªãŒã«çµè·¯,é
žåã¹ãã¬ã¹ã®äº¢é²ãã²ãèµ·ããã,ãããã®ææšã®è
çµç¹äžã®advanced glycation endproducts(AGEs)ãšãœã«ãããŒã«,è¡äžè質éé
žåéã¯,ããããç³å°¿ç
æ§è
çã©ããã§ææã«å¢å ããŠãããããã«å¯Ÿã,4çš®é¡ã®æŒ¢æ¹æ¹å€ãæäžãã矀ã§ã¯,ãããã®å Žåãè
çµç¹äžã®AGEsã¬ãã«ãææã«äœäžããŠãããããããœã«ãããŒã«å«éã¯å
«å³å°é»äžž,æŽè湯,æ¡æè¯èäžžæäžçŸ€ã§,è¡äžè質éé
žåéã¯æ¡æè¯èäžž,æž©èŸæ¹¯,æŽè湯æäžçŸ€ã§ææã«äœäžããŠããããŸãè
æ©èœãã©ã¡ãŒã¿ãŒã®ã¯ã¬ã¢ããã³ã¯ãªã¢ã©ã³ã¹ãšå°¿èçœææ³éã¯æ¡æè¯èäžž,å
«å³å°é»äžžæäžçŸ€ã§ææã«æ¹åããŠããããã®ããšãã,4çš®é¡ã®æŒ¢æ¹æ¹å€ã¯ããããç°ãªã£ãäœçšæ©åºã§,ç³å°¿ç
æ§è
çã®é²å±ãæå¶ããŠããå¯èœæ§ã瀺åããã
Confirmation that Luobuma ameliorates the deterioration of antioxidant defense in senescence-accelerated mice
To determine whether Luobuma extract ameliorates the deterioration in antioxidant defense with aging, the effect of Luobuma extract was investigated in senescence-accelerated mice (SAM). In comparison with AKR/N Slc mice, a strain consistent with SAM but exhibiting normal aging, SAM treated with extract showed a lower glutathione (GSH) and glutathione/glutathione disulfide (GSH/GSSG) ratio in the liver and kidney, and increased levels of malondialdehyde (MDA), a lipid peroxidation product. Administration of Luobuma extract increased the GSH level and GSH/GSSG ratio, and suppressed MDA production. On the other hand, the reduced activities of hepatic superoxide dismutase (SOD), glutathione peroxidase and glutathione reductase participating in the glutathione redox cycle were increased significantly by administration of Luobuma extract. A significant increase in renal SOD activity was also observed. In addition, the increased level of MDA in hepatic tissue was reduced in SAM given Luobuma extract. These findings indicate that Luobuma extract helps to ameliorate oxidative stress in SAM. çŸ
åžéº»ãšãã¹ãèåã«ãããé
žåé²åŸ¡æ©æ§ã«ãããªã圱é¿ãåãŒããŠãããã«ã€ããŠ,èåä¿é²ããŠã¹(SAM)ãçšãæ€èšãããSAMãšåã系統ã§ã¯ããã,éåžžã®èåéçšã蟿ãAKR/N SlcããŠã¹ã«æ¯ã¹,SAMã§ã¯è,è
çµç¹äžã®ã°ã«ã¿ããªã³ã¬ãã«ãšã°ã«ã¿ããªã³/ã°ã«ã¿ããªã³ãžã¹ã«ãã£ãæ¯ã¯äœäžã,è質éé
žåç©ã®ããã³ãžã¢ã«ãããã¯éã«å¢å ããŠãããäžæ¹,çŸ
åžéº»ãšãã¹ãæäžããSAMã§ã¯,ããããã©ã¡ãŒã¿ãŒãããããæ¹åã,ã°ã«ã¿ããªã³é
žåéå
ãµã€ã¯ã«ã«é¢ä¿ããŠããèçµç¹äžã®ã¹ãŒããŒãªãã·ããžã¹ã ã¿ãŒãŒ,ã°ã«ã¿ããªã³ãã«ãªãã·ããŒãŒ,ã°ã«ã¿ããªã³ã¬ãã¯ã¿ãŒãŒæŽ»æ§ãšè
çµç¹äžã®ã¹ãŒããŒãªãã·ããžã¹ã ã¿ãŒãŒæŽ»æ§ãææã«äžæããŠããããŸãèçµç¹äžã®ããã³ãžã¢ã«ããããäœäžã,SAMã§èªããããé
žåçã¹ãã¬ã¹ç¶æ
ãçŸ
åžéº»ãšãã¹ãç·©åããŠãã
Evaluation of Oriental medicines using a cultured renal epithelial cell line, LLC-PK_1 : Effects of Carthami Flos, Rhei Rhizoma and Astragali Radix
The effects of Carthami FlosïŒRhei Rhizoma and Astragali Radix extractïŒwhich have been proved to ameliorate renal failure in rats with glycerol-induced renal failureïŒwere examined in cell culture under three different culture conditionsïŒRhei Rhizomaãextract showed the most potent effect among the three crude drugs under any of the routineïŒhypoxia-reoxygenation and cisplatin exposure conditions employedïŒsuggesting that its favorable effect on proximal tubule function is due to suppressionãof lipid peroxidation via free radicalsïŒIn contrastïŒthis anti-cytotoxic activity was low in Astragali Radix extractïŒand almost nil in Carthami Flos extractïŒThese results indicate that Rhei RhizomaïŒAstragali Radix and Carthami Flos exert their actions on different sites in the kidney
Chiyu extract stimulates antioxidant defense ability in senescence-accelerated mice
The effect of chiyu extract on antioxidant defense alteration in senescence-accelerated mice (SAM) was examined. Comparison with AKR/N Slc mice, a strain consistent with SAM but exhibiting normal aging, showed a lower glutathione (GSH) level and glutathione/glutathione disulfide (GSH/ GSSG) ratio in the kidney and liver of SAM, whereas malondialdehyde (MDA), a lipid peroxidation product, was increased significantly. Administration of chiyu extract increased the GSH level and GSH/ GSSG ratio, and markedly suppressed MDA production. On the other hand, detection of renal enzymes related to the glutathione redox cycle showed that catalase and glutathione peroxidase activities were largely decreased in SAM, whereas chiyu extract reversed this tendency. The reduced activities of hepatic catalase and glutathione reductase were increased significantly by the extract. These findings suggest that a decline of the antioxidant defense system occurs in SAM, and that chiyu extract may have a beneficial effect in ameliorating oxidative stress or damage. èåä¿é²ããŠã¹(SAM)ã®æé
žåé²åŸ¡æ©æ§ã«å¯Ÿã,å°æ¥¡ãšãã¹ããããªã圱é¿ãåãŒããŠãããã«ã€ããŠ,SAMãšåã系統ã§ã¯ããã,éåžžã®èåéçšã蟿ãAKR/N SlcããŠã¹ãšæ¯èŒæ€èšããããã®çµæ,SAMã®è
,èã°ã«ã¿ããªã³ã¬ãã«ãšã°ã«ã¯ããªã³/ã°ã«ã¿ããªã³ãžã¹ã«ãã£ãæ¯ã¯äœäžã,è質éé
žåç©ã®ããã³ãžã¢ã«ãããã¯éã«ææã«äžæããŠããã,å°æ¥¡ãšãã¹ãæäžããSAMã§ã¯,ããããã©ã¡ãŒã¿ãŒãããããæ¹åããŠãããäžæ¹,ã°ã«ã¿ããªã³é
žåéå
ãµã€ã¯ã«ã«é¢ä¿ããŠããé
µçŽ ã®ãã¡,è
ã§ã¯ã«ã¿ã©ãŒãŒãšã°ã«ã¯ããªã³ãã«ãªãã·ããŒãŒæŽ»æ§ãSAMã§èããäœäžã,å°æ¥¡ãšãã¹æäžã«ãã£ãŠãããé
µçŽ ã®æŽ»æ§ãå埩ããŠãããèã«ãããŠãäœäžããŠããã«ã¿ã©ãŒãŒãšã°ã«ã¿ããªã³ã¬ãã¯ã¿ãŒãŒæŽ»æ§ããšãã¹æäžã«ããèããå埩ããŠããããããæèŠã¯,SAMã§èªããããæé
žåé²åŸ¡ç³»ã®äœäžã,å°æ¥¡ãšãã¹ã«ãã£ãŠæ¯æ£ãããããšã瀺åãããã®ã§ãã
Evaluation of Keishi-bukuryo-gan in a diabetic nephropathy model by comparison with aminoguanidine, butylated hydroxytoluene and captopril
æ¡æè¯èäžžã®ç³å°¿ç
æ§è
çã«å¯Ÿããäœçšã,ã¢ãã«ã©ãããçšãæ€èšãããè
æ©èœãã©ã¡ãŒã¿ãŒ,ç
ççµç¹åŠçæ€èšã«å ã,advanced glycation end products(AGEs)ã®èç©,é
žåã¹ãã¬ã¹ã«åãŒã圱é¿ã,ã¢ããã°ã¢ããžã³(AGEsé»å®³è¬),ã«ããããªã«(ã¢ã³ãžãªãã³ã·ã³å€æé
µçŽ é»å®³è¬),buthylated hydroxytoluene(BHT)(æé
žåå€)ãšã§æ¯èŒæ€èšãããæ¡æè¯èäžžã§ã¯è
æ©èœ(è¡æž
Cr,å°¿èçœææ³é)ãšç
çæèŠã®ææãªæ¹åäœçšãèªããã,ç³å°¿ç
æ§è
çã®é²å±ãæå¶ããããšãå®éšçã«æãããšãªã£ãã,ãã®ãããªè
ä¿è·äœçšã¯ã«ããããªã«ããã¯åŒ±ã,ã¢ããã°ã¢ããžã³ãšåçšåºŠã§ãã£ããBHTã«ã¯è
ä¿è·äœçšã¯èªããããªãã£ããè
çµç¹äžã®AGEsã®èç©ã«å¯ŸããŠã¯,æ¡æè¯èäžž,ã«ããããªã«,BHTãããããææã«äœäžããŠããã,ã¢ããã°ã¢ããžã³ã®äœçšããã¯åŒ±ãã£ããè
çµç¹äžã®è質éé
žåéã¯BHTã§æãäœäžã,æ¡æè¯èäžž,ã«ããããªã«ã§ãææã«äœäžããŠãããäžæ¹,è¡äžè質éé
žåã«å¯ŸããŠã¯,ãã¹ãŠã«ãããŠææãªäœäžäœçšãèªããããã,ã«ããããªã«ã§æã匷ãã£ãããã®ããšãã,æ¡æè¯èäžžã¯ã«ããããªã«ãã¢ããã°ã¢ããžã³ãšã¯ç°ãªã£ãæ©åºã§ç³å°¿ç
æ§è
çã®é²å±ãæå¶ããŠããå¯èœæ§ã瀺ãããã A study was done to investigate whether Keishi-bukuryo-gan can delay the progression of diabetic nephropathy in an experimentally induced diabetic nephropathy model. The efficacy of Keishi-bukuryo-gan against renal functional and structural changes and its influence on accumulation of advanced glycation end-products (AGEs) and oxidative stress were also examined by comparison with aminoguanidine (an AGEs inhibitor), butylated hydroxytoluene (BHT; an antioxidant) and captopril (an angiotensin converting enzyme inhibitor). Treatment with Keishi-bukuryo-gan for 10 weeks preserved renal function, as assessed in terms of proteinuria and serum creatinine, and prevented the morphological changes peculiar to diabetic nephropathy. However, its renoprotective activity was inferior to that of captopril and comparable to that of aminoguanidine. BHT lacked any of these effects. On the other hand, renal AGEs accumulation and oxidative stress were significantly enhanced in rats with untreated diabetic nephropathy compared with normal rats. Keishi-bukuryo-gan, captopril and BHT showed significant reduction of AGEs levels, but not to the extent shown by aminoguanidine. Renal lipid peroxidation levels were significantly lowered in the groups given Keishi-bukuryo-gan and captopril, but not to the extent shown in the rats given BHT. The reduction of serum lipid peroxidation levels by captopril was stronger than that by BHT. The effects of Keishi-bukuryo-gan and aminoguanidine on serum lipid peroxidation levels were similar to those of BHT. These results suggest that the pharmaceutical characteristics of Keishi-bukuryo-gan may differ from those of the other three medicines examined
Protective effect of Sanguisorbae Radix against apoptosis and function of renal tissues subjected to ischemia-reperfusion
DNA ladders were detected by gel electrophoresis of DNA obtained from rat kidney subjected to 60 min of ischemia followed by 24 h of reperfusion, indicating the involvement of apoptosis in ischemia-reperfusion injury. This ladder formation was significantly inhibited by oral administration of Sanguisorbae Radix extract to rats for 30 days prior to ischemia-reperfusion. In addition, blood levels of urea nitrogen and creatinine, two parameters of renal function, were markedly lower in the Sanguisorbae Radix-treated animals than in the untreated controls. These results suggest that Sanguisorbae Radix has potential for attenuating renal injury and accelerating the recovery of renal function after ischemia-reperfusion injury, which might involve inhibition of apoptosis. 60åéèè¡åŸ,24æéåçæµããã©ããè
ã®DNAã«ã©ããŒãåºçŸã,è
èè¡äžåçæµé害ã«ã¢ãããŒã·ã¹ãé¢äžããŠããããšã瀺åãããããã®ãããªDNAã®æçåã¯,å°æ¥¡ãšãã¹ãåãã£ãŠ30æ¥éçµå£æäžããå Žå,ææã«æå¶ãã,è
æ©èœã®ææšã®è¡äžå°¿çŽ çªçŽ ãšã¯ã¬ã¢ããã³ã¬ãã«ãå°æ¥¡ãšãã¹åŠç矀ã§èããäœäžããŠããããã®ããšãã,å°æ¥¡ã¯ã¢ãããŒã·ã¹ãé¢äžããè
èè¡äžåçæµé害ã軜æ»
ããŠ,è
æ©èœã®å埩ãã¯ãã£ãŠãããã®ãšæšæž¬ããã
Increase of radical in rats with adenine-induced renal failure is suppressed by Wen-Pi-Tang
We analyzed the free radical reaction in the body in vivo under the conditions of renal failure, using an L-band electron spin resonance apparatus. In rats with adenine-induced renal failure, the attenuation velocity of 3-carbamoyl-2,2,5,5-tetramethylpyrrolidine-N-oxyl was lowered in comparison with normal rats, indicating that they were in a state of augmented oxidation. In contrast, the attenuation velocity was higher in rats given Wen-Pi-Tang, showing a shift toward reduction. In the kidney of rats given Wen-Pi-Tang, we also found that a significant decrease in glutathione disulfide (GSSG) level caused an increase in the glutathione/GSSG ratio. In addition, there were significant reductions of increased thiobarbituric acid-reactive substance level and decreased superoxide dismutase and increased glutathione peroxidase activities, suggesting a decreased hydrogen peroxide production, which presumably drove the glutathione redox cycle toward reduction. The results of the present study suggest the possibility that Wen-Pi-Tang exerts an antioxidant effect through regulation of the redox cycle. L-ãã³ãESR(çäœèšæž¬çšESR)è£
眮ãçšã,è
äžå
šã«ãããçäœå
ããªãŒã©ãžã«ã«åå¿ã解æãããã¢ããã³èªçºè
äžå
šã©ããè
ã§ã¯,æ£åžžã©ãããã3-carbamoyl-2,2,5,5-tetramethylpyrrolidine-N-oxylã®æžè¡°é床ãé
延ã,é
žå亢é²ç¶æ
ã«ãã£ããããã«å¯Ÿã,æž©èŸæ¹¯æäžçŸ€ã§ã¯æžè¡°é床ãéãããšãªã,éå
æ¹åã«å€æããŠãããäžæ¹,æž©èŸæ¹¯æäžçŸ€ã®è
èã§ã¯å¢å ããã°ã«ã¿ããªã³ãžã¹ã«ãã£ãã¬ãã«ã®ææãªäœäžããã°ã«ã¿ããªã³/ã°ã«ã¿ããªã³ãžã¹ã«ãã£ãæ¯ã®äžæãèªããã,ãŸãå¢å ããããªãã«ãããŒã«é
žåå¿ç©è³ªã¬ãã«,äœäžããã¹ãŒããŒãªãã·ããžã¹ã ã¿ãŒãŒãšäžæããã°ã«ã¿ããªã³ã¬ãã¯ã¿ãŒãŒæŽ»æ§ã®ææãªäœäžãã,éé
žåæ°ŽçŽ ã®ç£çäœäžã瀺åãã,ã°ã«ã¿ããªã³é
žåéå
ãµã€ã¯ã«ãéå
æ¹åã«äœåããŠãããã®ãšèããããã以äžãã,æž©èŸæ¹¯ã¯é
žåéå
ãµã€ã¯ã«èª¿ç¯ãä»ããŠæé
žåäœçšãçºæ®ããå¯èœæ§ã瀺åããã
Effect of Luobuma leaves against oxidation of low-density lipoprotein : a cell culture assay
In a previous study, we observed an improvement in the atherosclerosis index, together with a decrease in blood cholesterol, in rats given Luobuma extract orally and fed a high-cholesterol diet. The present study was designed to examine the function of oxidized low-density lipoprotein (LDL) in atherosclerotic lesions, using cultured cells. When endothelial cells were cultured with LDL in the presence of Cu^, the release of thiobarbituric acid (TBA) -reactive substance and lactic dehydrogenase into the culture medium was increased, with a decrease in cell viability. However, when Luobuma extract was also present in the culture medium, changes in these parameters were more favorable. In another in vitro system using macrophages, the levels of TBA-reactive substance, total cholesterol and esterified cholesterol were all significantly lower in the presence of Luobuma extract than in its absence. There was also morphological evidence that foam cell formation through incorporation of oxidized LDL was suppressed. These findings indicate that Luobuma suppresses the progression of atherosclerosis, in which oxidized LDL is involved. å
ã«,é«ã³ã¬ã¹ãããŒã«é£æäžã©ããã«çŸ
åžéº»ãšãã¹ãçµå£æäžããå Žå,é«ã³ã¬ã¹ãããŒã«è¡çã®äœäžãšãšãã«åè硬åææ°ã®æ¹åäœçšãèªããããã®ã§,ä»å,ç²¥ç¶åè硬åç
å€ãžã®é
žåLDLã®æ©èœã现èãçšãæ€å¯žå¯žããããŸãå
ç®çŽ°èã«LDLãšCu^ãæ·»å ããŠå¹é€ããå Žå,å¹å°äžãžã®ããªãã«ãããŒã«é
žåå¿ç©è³ª,ç·LDHã®æŸåºãå¢å ããŠ,现èçåçã®äœäžã芳å¯ãããããããçŸ
åžéº»ãšãã¹æ·»å 矀ã§ã¯ããããã©ã¡ãŒã¿ãããããæ¹åã,ãŸããã¯ããã¡ãŒãžãçšããç³»ã§ãããªãã«ãããŒã«é
žåå¿ç©è³ª,ã³ã¬ã¹ãããŒã«ãšã¹ãã«,ã³ã¬ã¹ãããŒã«ãšã¹ãã«/éé¢ã³ã¬ã¹ãããŒã«æ¯ãããããç¡æ·»å 矀ããææã«äœäžã,圢æ
åŠçãªå€åãé
žåLDLã®ãšã蟌ã¿ã«äŒŽã泡沫åã®åœ¢æãæå¶ããç¥èŠãåŸãããããã®ããšãã,çŸ
åžéº»ã¯é
žåLDLãé¢äžããåè硬åã®é²å±éçšãæå¶ããããšãæãããšãªã£ã
- âŠ